Immune checkpoint inhibitor associated renally limited thrombotic microangiopathy – a clinical dilemma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint inhibitor associated renally limited thrombotic microangiopathy – a clinical dilemma

Published:2022-07 Issue: Volume:169 Page:126-130
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Badra Sherif^ORCID,Ruchi Rupam,Zeng Xu,Gordan Lucio,Shah Chintan V.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference15 articles.

1. KEYNOTE-189 investigators. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer;Gandhi;N Engl J Med,2018

2. Immune checkpoint inhibitor nephrotoxicity: Update;Shruti;Leaf Kidney,2020

3. The role of kidney biopsy in Immune Checkpoint Inhibitor-associated AKI. Arash Rashidi, Chintan Shah and Miroslav Sekulic Kidney,2022

4. Carboplatin-associated thrombotic microangiopathic hemolytic anemia;Walker;Cancer,1989

5. Thrombotic microangiopathy, cancer, and cancer drugs;Izzedine;Am J Kidney Dis,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to deal with renal toxicities from immune-based combination treatments in metastatic renal cell carcinoma. A nephrological consultation for Oncologists;Cancer Treatment Reviews;2024-04

2. The histomorphology of the senescent kidney – the clinical relevance of specimen and biopsy findings in the elderly native kidneys;Current Opinion in Urology;2024-02-26

3. Renal-Limited Thrombotic Microangiopathy in a Patient Who Received Gemcitabine, Ramucirumab, and Pembrolizumab: A Case Report and Literature Review;Cureus;2024-02-05

4. Management Update in Immunotherapy and Kidney Injury;Interdisciplinary Cancer Research;2024

5. Frequency and characteristics of chemotherapy‐associated thrombotic microangiopathy: Analysis from a large pharmacovigilance database;American Journal of Hematology;2023-09-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3